WallStreetZenWallStreetZen
Analyst Ranking
Bottom 2%
#4138 out of 4209 analysts
Average Return
-13.73%
Win Rate
32%28 out of 88
Risk vs Reward
Poor
Good

Luke Sergott's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Certara IncCERT
+73.51%$13.63$23.65
2022-10-06 -
2023-03-24
Strong Buy
Catalent IncCTLT
+43.14%$44.90$64.27
2022-11-02 -
2023-03-24
Strong Buy
Certara IncCERT
+41.96%$16.66$23.65
2022-08-17 -
2023-03-24
Strong Buy
Ppd IncPPD
+32.55%$35.67$47.28
2021-03-03 -
2021-12-07
Strong Buy
Catalent IncCTLT
+29.66%$49.57$64.27
2023-01-24 -
2023-03-24
Strong Buy

Luke Sergott's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Certara IncCERT
6Strong Buy$21.00-11.21%Maintains
24 days ago
Syneos Health IncSYNH
11Strong Sell$45.00+30.36%Maintains
25 days ago
Illumina IncILMN
8Strong Sell$150.00-31.82%Maintains
2 months ago
Catalent IncCTLT
7Strong Buy$82.00+27.59%Maintains
2 months ago
Twist Bioscience CorpTWST
7Strong Buy$32.00+97.78%Maintains
2 months ago
Thermo Fisher Scientific IncTMO
8Strong Buy$660.00+18.22%Maintains
2 months ago
Waters CorpWAT
4Strong Buy$380.00+26.68%Maintains
2 months ago
Perkinelmer IncPKI
6Hold$140.00+9.74%Maintains
2 months ago
Danaher CorpDHR
11Strong Buy$290.00+16.86%Maintains
2 months ago
Avantor IncAVTR
9Strong Buy$26.00+24.46%Maintains
2 months ago
Icon PLCICLR
7Strong Buy$260.00+25.77%Upgrades
2 months ago
Iqvia Holdings IncIQV
9Strong Buy$260.00+38.04%Maintains
2 months ago
Sotera Health CoSHC
8Strong Buy$22.00+27.02%Upgrades
2 months ago
Ortho Clinical Diagnostics Holdings PLCOCDX
2Hold$25.00N/ADowngrades
a year ago
Ppd IncPPD
1Strong Buy$42.00N/AInitiates Coverage On
2 years ago
Centogene NvCNTG
1Hold$21.00N/ADowngrades
3 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.